Johnson & Johnson ROE 2006-2018 | JNJ

Current and historical return on equity (ROE) values for Johnson & Johnson (JNJ) over the last 10 years.
Johnson & Johnson Annual ROE - Return on Equity
2017 0.00
2016 0.00
2015 0.00
2014 23.40
2013 18.68
2012 16.22
2011 16.95
2010 23.57
2009 24.25
2008 30.46
2007 24.41
2006 28.11
2005 25.99
Johnson & Johnson Quarterly ROE - Return on Equity
Q2 2018 6.29
Q1 2018 6.90
Q4 2017 -17.81
Q3 2017 5.09
Q2 2017 5.32
Q1 2017 6.29
Q4 2016 0.00
Q3 2016 5.87
Q2 2016 5.52
Q1 2016 6.14
Q4 2015 0.00
Q3 2015 4.69
Q2 2015 6.35
Q1 2015 6.36
Q4 2014 3.61
Q3 2014 6.20
Q2 2014 5.54
Q1 2014 6.17
Q4 2013 4.75
Q3 2013 4.27
Q2 2013 5.50
Q1 2013 5.23
Q4 2012 3.96
Q3 2012 4.12
Q2 2012 2.33
Q1 2012 6.37
Q4 2011 0.38
Q3 2011 5.20
Q2 2011 4.47
Q1 2011 5.81
Q4 2010 3.43
Q3 2010 5.96
Q2 2010 6.53
Q1 2010 8.55
Q4 2009 4.36
Q3 2009 6.64
Q2 2009 6.94
Q1 2009 8.01
Q4 2008 6.38
Q3 2008 7.24
Q2 2008 7.17
Q1 2008 7.89
Q4 2007 5.48
Q3 2007 5.85
Q2 2007 7.15
Q1 2007 6.29
Q4 2006 5.51
Q3 2006 6.80
Q2 2006 6.92
Q1 2006 8.04
Q4 2005 5.41
Q3 2005 6.89
Q2 2005 7.36
Q1 2005 8.44
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $349.931B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $245.020B 14.34
Novartis AG (NVS) Switzerland $189.637B 16.27
Merck (MRK) United States $181.642B 16.04
AbbVie (ABBV) United States $147.566B 14.42
Novo Nordisk (NVO) Denmark $116.361B 18.60
Eli Lilly (LLY) United States $110.975B 20.54
Sanofi (SNY) France $101.327B 12.82
GlaxoSmithKline (GSK) United Kingdom $100.338B 13.40
Bristol-Myers Squibb (BMY) United States $98.497B 17.83
AstraZeneca (AZN) United Kingdom $97.390B 10.71